Paper39025972
Malaria vaccines: a new era of prevention and control.
Duffy PE and 3 others. Nat Rev Microbiol, 2024. Cited by 92 papers, by iCite.
Cite this record
ConductScience Library. Malaria vaccines: a new era of prevention and control. Papers, record 39025972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39025972
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Malaria Vaccines | Major topic |
| Malaria | Major topic |
| Humans | |
| Animals | |
| Plasmodium | |
| Plasmodium vivax | |
| Pregnancy |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| ZIAAI001008 | NIH | NIH RePORTER | |||
| ZIAAI001056 | NIH | NIH RePORTER |
References180
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32183832 | Adverse pregnancy outcomes among women presenting at antenatal clinics in Ouélessébougou, Mali. | Reprod Health | 2020 | https://conductscience.org/library/papers/32183832 | PubMed |
| 2 | 16861644 | Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity. | Infect Immun | 2006 | https://conductscience.org/library/papers/16861644 | PubMed |
| 3 | 36087586 | Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/36087586 | PubMed |
| 4 | 36708738 | Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial. | Lancet Infect Dis | 2023 | https://conductscience.org/library/papers/36708738 | PubMed |
| 5 | 35963275 | Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/35963275 | PubMed |
| 6 | 26063320 | Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum. | Sci Rep | 2015 | https://conductscience.org/library/papers/26063320 | PubMed |
| 7 | 34223402 | Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination. | Med | 2021 | https://conductscience.org/library/papers/34223402 | PubMed |
| 8 | 27296848 | Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study. | J Infect Dis | 2016 | https://conductscience.org/library/papers/27296848 | PubMed |
| 9 | 27132023 | Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells. | Clin Immunol | 2016 | https://conductscience.org/library/papers/27132023 | PubMed |
| 10 | 33686061 | Predicting the public health impact of a malaria transmission-blocking vaccine. | Nat Commun | 2021 | https://conductscience.org/library/papers/33686061 | PubMed |
| 11 | 35293561 | Plasmodium falciparum merozoite surface protein 3 as a vaccine candidate: a brief review. | Rev Inst Med Trop Sao Paulo | 2022 | https://conductscience.org/library/papers/35293561 | PubMed |
| 12 | 17124530 | Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial. | PLoS Clin Trials | 2006 | https://conductscience.org/library/papers/17124530 | PubMed |
| 13 | 32724063 | Evaluation and modeling of direct membrane-feeding assay with Plasmodium vivax to support development of transmission blocking vaccines. | Sci Rep | 2020 | https://conductscience.org/library/papers/32724063 | PubMed |
| 14 | 406671 | An effective immunization of experimental monkeys against a human malaria parasite, Plasmodium falciparum. | Science | 1977 | https://conductscience.org/library/papers/406671 | PubMed |
| 15 | 37474653 | mRNA vaccine against malaria tailored for liver-resident memory T cells. | Nat Immunol | 2023 | https://conductscience.org/library/papers/37474653 | PubMed |
| 16 | 32566259 | Malaria vaccines since 2000: progress, priorities, products. | NPJ Vaccines | 2020 | https://conductscience.org/library/papers/32566259 | PubMed |
| 17 | 31092823 | Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy. | Nat Commun | 2019 | https://conductscience.org/library/papers/31092823 | PubMed |
| 18 | 26254338 | Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect. | J Immunol | 2015 | https://conductscience.org/library/papers/26254338 | PubMed |
| 19 | 33964223 | Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. | Lancet | 2021 | https://conductscience.org/library/papers/33964223 | PubMed |
| 20 | 15051281 | A large focus of naturally acquired Plasmodium knowlesi infections in human beings. | Lancet | 2004 | https://conductscience.org/library/papers/15051281 | PubMed |
Cited by62
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42869939 | Mosquito-based malaria control through genetic, microbial and immunological innovations. | Nat Rev Microbiol | 2026 | https://conductscience.org/library/papers/42869939 | PubMed |
| 42804534 | Proteome-wide characterization of Plasmodium vivax antigens using a high-density peptide array. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42804534 | PubMed |
| 42684012 | Malaria Prevalence Near African Mangroves: Negative Association With Mangrove Extent, but Positive Association With Mangrove Greenness. | Glob Chang Biol | 2026 | https://conductscience.org/library/papers/42684012 | PubMed |
| 42592156 | Noninvasive malaria detection beyond blood sampling. | Sens Diagn | 2026 | https://conductscience.org/library/papers/42592156 | PubMed |
| 42455589 | A Global Perspective of Childhood Vaccinations: Past, Present, and Future-From Smallpox to mRNA. | Acta Paediatr | 2026 | https://conductscience.org/library/papers/42455589 | PubMed |
| 42453291 | Effectiveness of the Smart Home Model for Integrated Malaria Prevention: A Case-Control Study in Oyam District, Uganda. | J Trop Med | 2026 | https://conductscience.org/library/papers/42453291 | PubMed |
| 42387124 | Seeking universal malaria-vaccine targets. | Nature | 2026 | https://conductscience.org/library/papers/42387124 | PubMed |
| 42295386 | Highly sensitive detection of species-specific malaria antigens using a cellulose nanobead-based lateral flow immunoassay. | Mikrochim Acta | 2026 | https://conductscience.org/library/papers/42295386 | PubMed |
| 42234703 | Structural basis for conserved and distinct antigen recognition by a lineage of malaria-protective antibodies. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42234703 | PubMed |
| 42227058 | Plasmepsins as Antimalarial Drug Targets-Then, Now, and the Future. | Med Res Rev | 2026 | https://conductscience.org/library/papers/42227058 | PubMed |
| 42199930 | Hypomorphic biliverdin reductase a mutations define bilirubin anti-malarial threshold. | iScience | 2026 | https://conductscience.org/library/papers/42199930 | PubMed |
| 42059554 | Paclitaxel-induced tubulin dysfunction stalls parasite development: synergistic potential with artemisinin against resistant strains. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42059554 | PubMed |
| 41980931 | Potent acridone antimalarial against all three life stages of Plasmodium. | Nat Commun | 2026 | https://conductscience.org/library/papers/41980931 | PubMed |
| 41977140 | Anti-GPI scFv as a Promising Tool for Intervention Against Cerebral Malaria in Mice. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977140 | PubMed |
| 41972578 | Malaria in the 21st Century: Global Disease Burden, Epidemiological Insights, and Strategic Control Approaches. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/41972578 | PubMed |
| 41970896 | Indole Peptidomimetics Show Potent and Selective Activity against Drug-Resistant Plasmodium falciparum. | ACS Omega | 2026 | https://conductscience.org/library/papers/41970896 | PubMed |
| 41961468 | Lymphoid-Tissue-on-Chip Recapitulates Human Antibody Responses In Vitro. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41961468 | PubMed |
| 41923211 | Distribution of Plasmodium falciparum apical membrane antigen-1 cluster one loop haplotypes and their association with malaria symptoms in Bandiagara, Mali. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/41923211 | PubMed |
| 41893813 | Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893813 | PubMed |
| 41851575 | Advancing global malaria control: therapeutic strategies, drug discovery, and formulation innovations. | Infection | 2026 | https://conductscience.org/library/papers/41851575 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39025972
GET https://conductscience.org/api/papers/v1/39025972/references?page=2